Exosome treatment for very premature babies
Part of Brain & nervous system, Heart & circulation, Mental health, Women’s health & pregnancy clinical trials.
This study tests whether giving tiny particles called exosomes through the nose can help protect the brains of very premature babies. It aims to see if this treatment can reduce brain damage and improve development.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born very early, between 25 and 27 weeks of pregnancy.
- Your baby must have no major birth defects or serious health conditions.
- Your baby must be expected to live and receive intensive care.
- Your baby must not be part of a multiple birth (like twins or triplets).
- Your baby must not be in another research study with an unapproved treatment.
- You must give written permission for your baby to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving tiny amounts of your own fresh breast milk directly into your baby's nose in the first few days after birth can help prevent bleeding in the brain (intraventricular hemorrhage) in extremely preterm babies. If this works, it could improve your baby's long-term brain health and development.
This study tests whether combining skin-to-skin holding with a 10-minute sound recording can help premature babies' brains develop better. If you have a baby born early (24–33 weeks), you may be able to take part.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This early-stage study (Phase 1) tests whether a tiny dose given through the nose is safe for people who have had a stroke. It uses exosomes made from adult umbilical cord stem cells, mainly to look for side effects and dosing safety.
This trial tests if exosomes from stem cells can help children with autism who haven't improved enough with standard behavioral therapy. It aims to see if this treatment is safe and effective for reducing autism symptoms.
This trial tests a new drug made from stem cell exosomes (CB-Exo-A600) to see if it can help people with mild to moderate Alzheimer's disease. It aims to slow down symptoms and improve quality of life.
Hear when a new Premature Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.